Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.52 |
| ▸ | ELANE | P08246 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.46 |
| ▸ | GSK3B | P49841 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.45 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.45 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | NSD2 | O96028 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11284785 | 0.98 | CYP19A1 (0.50) | CYP19A1ELANEPTPN1GSK3BTDP1 | |
| SCHEMBL11522681 | 0.88 | PTPN1 (0.53) | ELANEPTPN1GSK3BTDP1MAPT | |
| SCHEMBL16708741 | 0.85 | ELANE (0.70) | ELANEHPGDMAPTALDH1A1KMT2A | |
| SCHEMBL3441517 | 0.83 | PRSS1 (0.50) | CYP19A1ELANETDP1ATML3MBTL1 | |
| SCHEMBL43742 | 0.81 | KMT2A (0.61) | CYP19A1ELANETDP1ATML3MBTL1 | |
| SCHEMBL153387 | 0.81 | CYP19A1 (0.55) | CYP19A1ELANETDP1ATML3MBTL1 | |
| SCHEMBL11545009 | 0.81 | PRSS1 (0.57) | CYP19A1ELANETDP1ATML3MBTL1 | |
| SCHEMBL6699565 | 0.81 | HSD17B10 (0.52) | ELANEGSK3BHSD17B10KMT2AHTT | |
| SCHEMBL231450 | 0.79 | CYP19A1 (0.53) | CYP19A1ELANETDP1ATML3MBTL1 | |
| SCHEMBL11495143 | 0.79 | CYP19A1 (0.53) | CYP19A1ELANETDP1ATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 412 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12509819-B2 | Micro-nano structure-based super-hydrophobic fabric and preparation method therefor | SOOCHOW UNIVERSITY (CN) | 2025-12-30 | — | — | US | claimed |
| CN-119529222-A | Flexible photosensitive polyurethane film and preparation method thereof | 广东工业大学 | 2025-02-28 | — | — | CN | claimed |
| US-20230416977-A1 | MICRO-NANO STRUCTURE-BASED SUPER-HYDROPHOBIC FABRIC AND PREPARATION METHOD THEREFOR | SOOCHOW UNIVERSITY (CN) | 2023-12-28 | — | — | US | claimed |
| CN-116601181-A | Polymers with low dispersibility initiated by near infrared light and iron catalysts | 弗祖马光子与可持续材料有限公司 | 2023-08-15 | — | — | CN | claimed |
| CN-110156735-B | Formononetin derivative and preparation method and application thereof | 天津国际生物医药联合研究院 | 2023-05-12 | — | — | CN | claimed |
| CN-115852684-A | Cotton fabric dyeing method | 绍兴市上虞丰达染整有限公司 | 2023-03-28 | — | — | CN | claimed |
| CN-113089339-B | Anti-sticking lining cloth | 东莞易昌塑胶布业有限公司 | 2022-11-08 | — | — | CN | claimed |
| CN-112144316-B | Nano-cellulose modified acrylic resin, preparation method thereof and decorative paper | 广东福美新材料科技有限公司 | 2022-09-09 | — | — | CN | claimed |
| CN-112878053-B | Micro-nano structure based super-hydrophobic fabric and preparation method thereof | 苏州大学 | 2022-03-15 | — | — | CN | claimed |
| CN-113089339-A | Anti-sticking lining cloth | 东莞易昌塑胶布业有限公司 | 2021-07-09 | — | — | CN | claimed |
| CN-112878053-A | Micro-nano structure based super-hydrophobic fabric and preparation method thereof | 苏州大学 | 2021-06-01 | — | — | CN | claimed |
| CN-112144316-A | Nano-cellulose modified acrylic resin, preparation method thereof and decorative paper | 广东福美新材料科技有限公司 | 2020-12-29 | — | — | CN | claimed |
| CN-110256264-A | A kind of synthetic method of Memantine glycine | 浙江华海药业股份有限公司 | 2019-09-20 | — | — | CN | claimed |
| CN-110156735-A | Formononetin derivative and its preparation method and application | 天津国际生物医药联合研究院 | 2019-08-23 | — | — | CN | claimed |
| CN-105263913-A | Thio-1,2,4-triazole derivatives and method for preparing the same | SUNSHINE LAKE PHARMA CO LTD | 2016-01-20 | — | — | CN | claimed |
| WO-2015059679-A1 | IMPROVED PROCESS FOR THE PREPARATION OF ELIGLUSTAT | DR. REDDY'S LABORATORIES LIMITED (IN) | 2015-04-30 | — | — | WO | claimed |
| WO-2014198241-A1 | THIO-1,2,4-TRIAZOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2014-12-18 | — | — | WO | claimed |
| US-20110091957-A1 | PROTEIN-POLYMER CONJUGATES AND SYNTHESIS THEREOF | PITTSBURGH, UNIVERSITY OF - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2011-04-21 | — | — | US | claimed |
| US-20070123646-A1 | Protein-polymer conjugates and synthesis thereof | PITTSBURGH, UNIVERSITY OF | 2007-05-31 | — | — | US | claimed |
| US-20260137819-A1 | FOLLICLE-STIMULATING HORMONE RECEPTOR (FSHR) TARGETED THERAPEUTICS AND USES THEREOF | RADIONETICS ONCOLOGY INC (US) | 2026-05-21 | — | — | US | disclosed |
| US-12509819-B2 | Micro-nano structure-based super-hydrophobic fabric and preparation method therefor | SOOCHOW UNIVERSITY (CN) | 2025-12-30 | — | — | US | disclosed |
| EP-4129965-B1 | THERMOPLASTIC RESIN HAVING CARBONATE BOND | MITSUBISHI CHEM CORP (JP) | 2025-12-17 | — | — | EP | disclosed |
| US-12473688-B2 | Carbene co-grafting modified fabric, preparation and application thereof | SOOCHOW UNIVERSITY (CN) | 2025-11-18 | — | — | US | disclosed |
| WO-2025229046-A1 | SUBSTITUTED HYDROQUINOLINES FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME | MOLIUS SAGLIK TEKNOLOJILERI ANONIM SIRKETI (TR) | 2025-11-06 | — | — | WO | disclosed |
| EP-4644375-A1 | SUBSTITUTED HYDROQUINOLINES FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME | Molius Saglik Teknolojileri Anonim Sirketi (TR) | 2025-11-05 | — | — | EP | disclosed |
| EP-4598928-A1 | FOLLICLE-STIMULATING HORMONE RECEPTOR (FSHR) TARGETED THERAPEUTICS AND USES THEREOF | Radionetics Oncology, Inc. (US) | 2025-08-13 | — | — | EP | disclosed |
| CN-119859216-A | Polar functionalized conjugated diene polymer and preparation method thereof | 东华大学 | 2025-04-22 | — | — | CN | disclosed |
| CN-119529222-A | Flexible photosensitive polyurethane film and preparation method thereof | 广东工业大学 | 2025-02-28 | — | — | CN | disclosed |
| CN-113956290-B | Preparation method of zoledronic acid impurity B | 常州方圆制药有限公司 | 2025-01-10 | — | — | CN | disclosed |
| US-20240409573-A1 | CALICHEAMICIN DERIVATIVES AND ANTIBODY DRUG CONJUGATES THEREOF | PFIZER INC. (US) | 2024-12-12 | — | — | US | disclosed |
| CN-118812589-A | Trialkylphosphine oxide compound derivative and preparation method thereof | 北京大学 | 2024-10-22 | — | — | CN | disclosed |
| US-20240344265-A1 | CARBENE CO-GRAFTING MODIFIED FABRIC, PREPARATION AND APPLICATION THEREOF | SOOCHOW UNIVERSITY (CN) | 2024-10-17 | — | — | US | disclosed |
| WO-2024171925-A1 | CRYSTAL OF DIESTER COMPOUND HAVING BINAPHTHYL SKELETON AND PRODUCTION METHOD THEREOF | 田岡化学工業株式会社 | 2024-08-22 | — | — | WO | disclosed |
| US-12065541-B2 | Thermoplastic resin, optical film made therefrom, diol compound, diester compound | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-08-20 | — | — | US | disclosed |
| EP-4400490-A2 | THERMOPLASTIC RESIN HAVING CARBONATE BOND | Mitsubishi Chemical Corporation (JP) | 2024-07-17 | — | — | EP | disclosed |
| US-12037352-B2 | Perfluoropolyether compound containing carboxyl group | Guangzhou Ur Materials Technology Co., Ltd. (CN) | 2024-07-16 | — | — | US | disclosed |
| US-12037352-B2 | Perfluoropolyether compound containing carboxyl group | Guangzhou Ur Materials Technology Co., Ltd. (CN) | 2024-07-16 | — | — | US | disclosed |
| CN-115087648-B | Compound, thermoplastic resin, optical member, and optical lens | 三菱化学株式会社 | 2024-07-02 | — | — | CN | disclosed |
| US-11993625-B2 | Calicheamicin derivatives and antibody drug conjugates thereof | PFIZER, INC. (US) | 2024-05-28 | — | — | US | disclosed |
| CN-117964503-A | Method for synthesizing alpha-trifluoromethyl ammonia compound by photocatalysis | 华中科技大学 | 2024-05-03 | — | — | CN | disclosed |
| CN-115246826-B | Quaternary ammonium salt isoxazoline compound, its preparation and application as insecticidal and bactericidal agent | 瑞普（天津）生物药业有限公司 | 2024-04-12 | — | — | CN | disclosed |
| WO-2024077006-A1 | FOLLICLE-STIMULATING HORMONE RECEPTOR (FSHR) TARGETED THERAPEUTICS AND USES THEREOF | RADIONETICS ONCOLOGY, INC. (US) | 2024-04-11 | — | — | WO | disclosed |
| CN-108155370-B | Polymerization of anode active material particles having synthetic SEI layer by grafting to backbone method | 罗伯特·博世有限公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-108155354-B | Polymerization of anode active material particles having a synthetic SEI layer by grafting from a main chain | 罗伯特·博世有限公司 | 2024-03-22 | — | — | CN | disclosed |
| US-20230416977-A1 | MICRO-NANO STRUCTURE-BASED SUPER-HYDROPHOBIC FABRIC AND PREPARATION METHOD THEREFOR | SOOCHOW UNIVERSITY (CN) | 2023-12-28 | — | — | US | disclosed |
| CN-113950500-B | Thermoplastic resin, optical film comprising the same, diol compound, and diester compound | 三菱化学株式会社 | 2023-11-03 | — | — | CN | disclosed |
| US-11793881-B2 | Polyethylene glycol conjugate medicament, preparation method therefor and use thereof | Chongqing Upgra Biotechnology Co., Ltd. (CN) | 2023-10-24 | — | — | US | disclosed |
| EP-3988599-B1 | THERMOPLASTIC RESIN, OPTICAL FILM MADE THEREFROM, DIOL COMPOUND, DIESTER COMPOUND | MITSUBISHI CHEM CORP (JP) | 2023-10-18 | — | — | EP | disclosed |
| WO-2023155368-A1 | CARBENE CO-GRAFTED MODIFIED FABRIC, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | 苏州大学 | 2023-08-24 | — | — | WO | disclosed |
| CN-110128843-B | Fluorescent dye and preparation method and application thereof | 深圳大学 | 2023-07-14 | — | — | CN | disclosed |
| US-11697644-B2 | Process for synthesis of eliglustat and intermediate compounds thereof | ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD. (CN) | 2023-07-11 | — | — | US | disclosed |
| US-11697644-B2 | Process for synthesis of eliglustat and intermediate compounds thereof | ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD. (CN) | 2023-07-11 | — | — | US | disclosed |
| CN-114874119-B | Method for synthesizing 3, 4-dialkylated-4-pyrroline-2-one derivative by photocatalysis | 昆明学院 | 2023-06-06 | — | — | CN | disclosed |
| CN-110156735-B | Formononetin derivative and preparation method and application thereof | 天津国际生物医药联合研究院 | 2023-05-12 | — | — | CN | disclosed |
| CN-112851928-B | Polyethylene glycol coupling drug, preparation method and application thereof | 重庆阿普格雷生物科技有限公司 | 2023-04-25 | — | — | CN | disclosed |
| CN-109689663-B | MENIN-MLL interacting spirobicyclic inhibitors | 詹森药业有限公司 | 2023-04-14 | — | — | CN | disclosed |
| CN-115852684-A | Cotton fabric dyeing method | 绍兴市上虞丰达染整有限公司 | 2023-03-28 | — | — | CN | disclosed |
| CN-115852684-A | Cotton fabric dyeing method | 绍兴市上虞丰达染整有限公司 | 2023-03-28 | — | — | CN | disclosed |
| US-20230088403-A1 | POLYETHYLENE GLYCOL CONJUGATE MEDICAMENT, PREPARATION METHOD THEREFOR AND USE THEREOF | Chongqing Upgra Biotechnology Co., Ltd. (CN) | 2023-03-23 | — | — | US | disclosed |
| US-20230039319-A1 | DEUTERIUM-ENRICHED SUBSTITUTED PHENOXYPHENYL ACETIC ACIDS AND ACYLSULFONAMIDES | DHANOA DALJIT SINGH (US) | 2023-02-09 | — | — | US | disclosed |
| EP-4129965-A1 | THERMOPLASTIC RESIN HAVING CARBONATE BOND | Mitsubishi Chemical Corporation (JP) | 2023-02-08 | — | — | EP | disclosed |
| CN-114481608-B | Carbene co-grafting modified fabric and preparation method and application thereof | 苏州大学 | 2022-12-30 | — | — | CN | disclosed |
| CN-113089339-B | Anti-sticking lining cloth | 东莞易昌塑胶布业有限公司 | 2022-11-08 | — | — | CN | disclosed |
| EP-4066861-A1 | POLYETHYLENE GLYCOL CONJUGATE MEDICAMENT, PREPARATION METHOD THERFOR AND USE THEREOF | Chongqing Upgra Biotechnology Co., Ltd. (CN) | 2022-10-05 | — | — | EP | disclosed |
| CN-112144316-B | Nano-cellulose modified acrylic resin, preparation method thereof and decorative paper | 广东福美新材料科技有限公司 | 2022-09-09 | — | — | CN | disclosed |
| WO-2022165777-A1 | MICRO-NANO STRUCTURE-BASED SUPER-HYDROPHOBIC FABRIC AND PREPARATION METHOD THEREFOR | 苏州大学 | 2022-08-11 | — | — | WO | disclosed |
| CN-114874119-A | Method for photocatalytic synthesis of 3, 4-dialkyl-4-pyrroline-2-one derivative | 昆明学院 | 2022-08-09 | — | — | CN | disclosed |
| US-20220185788-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF ELIGLUSTAT AND ITS INTERMEDIATE | PIRAMAL PHARMA LIMITED (IN) | 2022-06-16 | — | — | US | disclosed |
| EP-3744810-B1 | FLUORESCENT DYE, PREPARATION METHOD THEREFOR AND USE THEREOF | UNIV SHENZHEN (CN) | 2022-06-01 | — | — | EP | disclosed |
| CN-114481608-A | Carbene co-grafted modified fabric and preparation method and application thereof | 苏州大学 | 2022-05-13 | — | — | CN | disclosed |
| EP-3988599-A1 | THERMOPLASTIC RESIN, OPTICAL FILM MADE THEREFROM, DIOL COMPOUND, DIESTER COMPOUND | Mitsubishi Chemical Corporation (JP) | 2022-04-27 | — | — | EP | disclosed |
| US-20220081510-A1 | THERMOPLASTIC RESIN, OPTICAL FILM MADE THEREFROM, DIOL COMPOUND, DIESTER COMPOUND | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-03-17 | — | — | US | disclosed |
| CN-112878053-B | Micro-nano structure based super-hydrophobic fabric and preparation method thereof | 苏州大学 | 2022-03-15 | — | — | CN | disclosed |
| EP-3941917-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF ELIGLUSTAT AND ITS INTERMEDIATE | Piramal Pharma Limited (IN) | 2022-01-26 | — | — | EP | disclosed |
| CN-113956290-A | Preparation method of zoledronic acid impurity B | 常州方圆制药有限公司 | 2022-01-21 | — | — | CN | disclosed |
| CN-113950500-A | Thermoplastic resin, optical film comprising the same, diol compound, and diester compound | 三菱化学株式会社 | 2022-01-18 | — | — | CN | disclosed |
| CN-113089339-A | Anti-sticking lining cloth | 东莞易昌塑胶布业有限公司 | 2021-07-09 | — | — | CN | disclosed |
| WO-2021118826-A1 | DEUTERIUM-ENRICHED SUBSTITUTED PHENOXYPHENYL ACETIC ACIDS AND ACYLSULFONAMIDES | DHANOA DALJIT (US) | 2021-06-17 | — | — | WO | disclosed |
| US-20210171507-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYLTRANSFERASE INHIBITORS | GENZYME CORPORATION | 2021-06-10 | — | — | US | disclosed |
| US-20210171507-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYLTRANSFERASE INHIBITORS | GENZYME CORPORATION | 2021-06-10 | — | — | US | disclosed |
| WO-2021104120-A1 | POLYETHYLENE GLYCOL CONJUGATE MEDICAMENT, PREPARATION METHOD THERFOR AND USE THEREOF | 重庆阿普格雷生物科技有限公司 | 2021-06-03 | — | — | WO | disclosed |
| CN-112878053-A | Micro-nano structure based super-hydrophobic fabric and preparation method thereof | 苏州大学 | 2021-06-01 | — | — | CN | disclosed |
| CN-112851928-A | Polyethylene glycol coupled drug, preparation method and application thereof | 重庆阿普格雷生物科技有限公司 | 2021-05-28 | — | — | CN | disclosed |
| US-10889719-B2 | Fluorescent dye, preparation method therefor and use thereof | SHENZHEN UNIVERSITY (CN) | 2021-01-12 | — | — | US | disclosed |
| CN-112144316-A | Nano-cellulose modified acrylic resin, preparation method thereof and decorative paper | 广东福美新材料科技有限公司 | 2020-12-29 | — | — | CN | disclosed |
| CN-112088082-A | 3D printing component using dual light sources to control solidification position | 福特全球技术公司 | 2020-12-15 | — | — | CN | disclosed |
| EP-3744810-A1 | FLUORESCENT DYE, PREPARATION METHOD THEREFOR AND USE THEREOF | Shenzhen University (CN) | 2020-12-02 | — | — | EP | disclosed |
| WO-2020194138-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF ELIGLUSTAT AND ITS INTERMEDIATE | Piramal Enterprises Limited (IN) | 2020-10-01 | — | — | WO | disclosed |
| CN-107619384-B | Benzo-heterocycle derivative, preparation method and application thereof in medicine | 江苏恒瑞医药股份有限公司 | 2020-07-28 | — | — | CN | disclosed |
| US-20200095425-A1 | FLUORESCENT DYE, PREPARATION METHOD THEREFOR AND USE THEREOF | SHENZHEN UNIVERSITY (CN) | 2020-03-26 | — | — | US | disclosed |
| EP-3611171-A1 | METHOD FOR SYNTHESIS OF ELIGLUSTAT AND INTERMEDIATE COMPOUNDS THEREOF | Zhejiang Ausun Pharmaceutical Co., Ltd. (CN) | 2020-02-19 | — | — | EP | disclosed |
| WO-2020020365-A1 | METHOD FOR PREPARING OPTICALLY ACTIVE ELIGLUSTAT | 中国医学科学院药物研究所 | 2020-01-30 | — | — | WO | disclosed |
| US-20190345186-A1 | CALICHEAMICIN DERATIVES AND ANTIBODY DRUG CONJUGATES THEREOF | PFIZER INC. (US) | 2019-11-14 | — | — | US | disclosed |
| US-20190322649-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYLTRANSFERASE INHIBITORS | GENZYME CORPORATION | 2019-10-24 | — | — | US | disclosed |
| US-20190322649-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYLTRANSFERASE INHIBITORS | GENZYME CORPORATION | 2019-10-24 | — | — | US | disclosed |
| CN-110256264-A | A kind of synthetic method of Memantine glycine | 浙江华海药业股份有限公司 | 2019-09-20 | — | — | CN | disclosed |
| CN-108484601-B | Contain the benzothiazine -4- ketone compounds and preparation method thereof of 2,8- diaza spiro [4.5] decane segment | 浙江司太立制药股份有限公司 | 2019-09-13 | — | — | CN | disclosed |
| CN-110156735-A | Formononetin derivative and its preparation method and application | 天津国际生物医药联合研究院 | 2019-08-23 | — | — | CN | disclosed |
| US-10385042-B2 | Inhibitors of the enzyme UDP-glucose: N-acyl-sphingosine glucosyltransferase | CONCERT PHARMACEUTICALS, INC. (US) | 2019-08-20 | — | — | US | disclosed |
| CN-110128843-A | Fluorescent dye and its preparation method and application | 深圳大学 | 2019-08-16 | — | — | CN | disclosed |
| CN-109879769-A | A kind of bromo element recycles the method for preparing aminomethylbenzoic acid | 邯郸市赵都精细化工有限公司 | 2019-06-14 | — | — | CN | disclosed |
| CN-107188837-B | A kind of synthetic method of α-acyl group high allyl thio-ether type compounds | 温州大学 | 2019-05-28 | — | — | CN | disclosed |
| EP-2691402-B1 | BIFUNCTIONAL HYDROXY-BISPHOSPHONIC ACID DERIVATIVES | ATLANTHERA (FR) | 2019-05-08 | — | — | EP | disclosed |
| CN-109403028-A | A kind of method of modifying and modified heterocycle aramid fiber of heterocycle aramid fiber | 四川大学 | 2019-03-01 | — | — | CN | disclosed |
| WO-2018193090-A2 | PROCESS FOR PREPARATION OF ELIGLUSTAT HEMITARTRATE AND INTERMEDIATES THEREOF | AMNEAL PHARMACEUTICALS COMPANY GMBH (CH) | 2018-10-25 | — | — | WO | disclosed |
| CN-108586723-A | Polycondensation resin and optical film formed therefrom | 三菱化学株式会社 | 2018-09-28 | — | — | CN | disclosed |
| CN-108484601-A | Benzothiazine -4- ketone compounds and preparation method thereof containing 2,8- diaza spiros [4.5] decane segment | 浙江司太立制药股份有限公司 | 2018-09-04 | — | — | CN | disclosed |
| WO-2018138591-A1 | CALICHEAMICIN DERIVATIVES AND ANTIBODY DRUG CONJUGATES THEREOF | PFIZER INC. (US) | 2018-08-02 | — | — | WO | disclosed |
| WO-2018138591-A1 | CALICHEAMICIN DERIVATIVES AND ANTIBODY DRUG CONJUGATES THEREOF | PFIZER INC. (US) | 2018-08-02 | — | — | WO | disclosed |
| US-9988364-B1 | Process for synthesis of Eliglustat and intermediate compounds thereof | ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD. (CN) | 2018-06-05 | — | — | US | disclosed |
| CN-106062035-B | Polycondensation resin and optical film formed therefrom | 三菱化学株式会社 | 2018-05-29 | — | — | CN | disclosed |
| US-20180086743-A1 | INHIBITORS OF THE ENZYME UDP-GLUCOSE: N-ACYL-SPHINGOSINE GLUCOSYLTRANSFERASE | CONCERT PHARMACEUTICALS, INC. (US) | 2018-03-29 | — | — | US | disclosed |
| US-20180086743-A1 | INHIBITORS OF THE ENZYME UDP-GLUCOSE: N-ACYL-SPHINGOSINE GLUCOSYLTRANSFERASE | CONCERT PHARMACEUTICALS, INC. (US) | 2018-03-29 | — | — | US | disclosed |
| CN-107619384-A | Benzheterocyclic derivatives, its preparation method and its application in medicine | 江苏恒瑞医药股份有限公司 | 2018-01-23 | — | — | CN | disclosed |
| CN-105263913-B | Thio 1,2,4 triazole derivative and preparation method thereof | 广东东阳光药业有限公司 | 2017-12-15 | — | — | CN | disclosed |
| US-9828349-B2 | 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity | EXONHIT THERAPEUTICS SA (FR) | 2017-11-28 | — | — | US | disclosed |
| US-20170334888-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYLTRANSFERASE INHIBITORS | GENZYME CORPORATION | 2017-11-23 | — | — | US | disclosed |
| US-20170334888-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYLTRANSFERASE INHIBITORS | GENZYME CORPORATION | 2017-11-23 | — | — | US | disclosed |
| US-20170334888-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYLTRANSFERASE INHIBITORS | GENZYME CORPORATION | 2017-11-23 | — | — | US | disclosed |
| US-9783528-B2 | Inhibitors of the enzyme UDP-glucose: N-acyl-sphingosine glucosyltransferase | CONCERT PHARMACEUTICALS, INC. (US) | 2017-10-10 | — | — | US | disclosed |
| US-9783528-B2 | Inhibitors of the enzyme UDP-glucose: N-acyl-sphingosine glucosyltransferase | CONCERT PHARMACEUTICALS, INC. (US) | 2017-10-10 | — | — | US | disclosed |
| US-9783528-B2 | Inhibitors of the enzyme UDP-glucose: N-acyl-sphingosine glucosyltransferase | CONCERT PHARMACEUTICALS, INC. (US) | 2017-10-10 | — | — | US | disclosed |
| CN-107188837-A | A kind of synthetic method of α acyl groups high allyl thio-ether type compounds | 温州大学 | 2017-09-22 | — | — | CN | disclosed |
| EP-3189091-A2 | MAIN CHAIN POLYAMINES | Genzyme Corporation (US) | 2017-07-12 | — | — | EP | disclosed |
| US-20170182087-A1 | MAIN CHAIN POLYAMINES | GENZYME CORPORATION (US) | 2017-06-29 | — | — | US | disclosed |
| WO-2017068496-A1 | IMPROVED PROCESS FOR THE PREPARATION OF ELIGLUSTAT AND ITS SALTS | DR. REDDY' S LABORATORIES LIMITED (IN) | 2017-04-27 | — | — | WO | disclosed |
| US-9546161-B2 | Synthesis of UDP-glucose: N-acylsphingosine glucosyl transferase inhibitors | GENZYME CORPORATION (US) | 2017-01-17 | — | — | US | disclosed |
| US-9546161-B2 | Synthesis of UDP-glucose: N-acylsphingosine glucosyl transferase inhibitors | GENZYME CORPORATION (US) | 2017-01-17 | — | — | US | disclosed |
| US-9546161-B2 | Synthesis of UDP-glucose: N-acylsphingosine glucosyl transferase inhibitors | GENZYME CORPORATION (US) | 2017-01-17 | — | — | US | disclosed |
| CN-106187927-A | A kind of preparation method of Lesinurad intermediate | 山东川成医药股份有限公司 | 2016-12-07 | — | — | CN | disclosed |
| CN-106062035-A | Polycondensation resin and optical film formed therefrom | 三菱化学株式会社 | 2016-10-26 | — | — | CN | disclosed |
| CN-104718217-B | Phosphorus-containing aluminum carboxylate salt flame retardant | 陶氏环球技术有限责任公司 | 2016-08-31 | — | — | CN | disclosed |
| US-9399628-B2 | 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity | ALLERGAN, INC. (US) | 2016-07-26 | — | — | US | disclosed |
| CN-102718748-B | There is the compound of analgesic activities and/or Immuno-stimulant activity | 阿勒根公司 | 2016-06-22 | — | — | CN | disclosed |
| CN-103254203-B | Five yuan of urea rings coumarin derivative or its officinal salt and purposes | SICHUAN UNIVERSITY (CN) | 2016-05-11 | — | — | CN | disclosed |
| US-9314466-B2 | Methods for treating cognitive disorders using 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds | ALLERGAN, INC. (US) | 2016-04-19 | — | — | US | disclosed |
| US-20160083371-A1 | 1-ARYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 1-HETEROARYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES AND RELATED COMPOUNDS HAVING ANALGESIC AND/OR IMMUNO STIMULANT ACTIVITY | EXONHIT THERAPEUTICS SA (FR) | 2016-03-24 | — | — | US | disclosed |
| US-20160068519-A1 | INHIBITORS OF THE ENZYME UDP-GLUCOSE: N-ACYL-SPHINGOSINE GLUCOSYLTRANSFERASE | CONCERT PHARMACEUTICALS, INC. (US) | 2016-03-10 | — | — | US | disclosed |
| US-20160068519-A1 | INHIBITORS OF THE ENZYME UDP-GLUCOSE: N-ACYL-SPHINGOSINE GLUCOSYLTRANSFERASE | CONCERT PHARMACEUTICALS, INC. (US) | 2016-03-10 | — | — | US | disclosed |
| US-20160068519-A1 | INHIBITORS OF THE ENZYME UDP-GLUCOSE: N-ACYL-SPHINGOSINE GLUCOSYLTRANSFERASE | CONCERT PHARMACEUTICALS, INC. (US) | 2016-03-10 | — | — | US | disclosed |
| US-9278943-B2 | Methods of using as analgesics 1-benzyl-1-hydroxy-2, 3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds | EXONHIT THERAPEUTICS SA (FR) | 2016-03-08 | — | — | US | disclosed |
| US-20160051555-A9 | METHODS FOR TREATING COGNITIVE DISORDERS USING 1-BENZYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 3-BENZYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS | ALLERGAN, INC. (US) | 2016-02-25 | — | — | US | disclosed |
| CN-105263913-A | Thio-1,2,4-triazole derivatives and method for preparing the same | SUNSHINE LAKE PHARMA CO LTD | 2016-01-20 | — | — | CN | disclosed |
| WO-2016007821-A2 | MAIN CHAIN POLYAMINES | GENZYME CORPORATION (US) | 2016-01-14 | — | — | WO | disclosed |
| US-9173946-B2 | Bifunctional hydroxy-bisphosphonic acid derivatives | ATLANTHERA (FR) | 2015-11-03 | — | — | US | disclosed |
| US-9173946-B2 | Bifunctional hydroxy-bisphosphonic acid derivatives | ATLANTHERA (FR) | 2015-11-03 | — | — | US | disclosed |
| US-20150231140-A1 | METHODS FOR TREATING COGNITIVE DISORDERS USING 1-BENZYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 3-BENZYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS | ALLERGAN, INC. (US) | 2015-08-20 | — | — | US | disclosed |
| CN-104718217-A | Phosphorous acid-containing aluminum carboxylate flame retardants | DOW GLOBAL TECHNOLOGIES INC | 2015-06-17 | — | — | CN | disclosed |
| US-20150148534-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYL TRANSFERASE INHIBITORS | GENZYME CORPORATION | 2015-05-28 | — | — | US | disclosed |
| US-20150148534-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYL TRANSFERASE INHIBITORS | GENZYME CORPORATION | 2015-05-28 | — | — | US | disclosed |
| US-20150148534-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYL TRANSFERASE INHIBITORS | GENZYME CORPORATION | 2015-05-28 | — | — | US | disclosed |
| CN-103408414-B | Preparation method of 2-hydroxyl-4-substituted arone compound | BEIJING GREENCHEM TECHNOLOGY CO LTD | 2015-05-13 | — | — | CN | disclosed |
| CN-104614938-A | ARYL ACETATE ONIUM MATERIALS | ROHM & HAAS ELECT MAT | 2015-05-13 | — | — | CN | disclosed |
| WO-2015059679-A1 | IMPROVED PROCESS FOR THE PREPARATION OF ELIGLUSTAT | DR. REDDY'S LABORATORIES LIMITED (IN) | 2015-04-30 | — | — | WO | disclosed |
| CN-104402728-A | Preparation method for 5-chlorine-2-hydroxyl-3-nitroacetophenone | SHANDONG JINCHENG PHARMACEUTICAL & CHEMICAL CO LTD | 2015-03-11 | — | — | CN | disclosed |
| CN-102746281-B | 4-1,2,3-triazole-coumarin derivative and its preparation method and application | UNIV SICHUAN | 2015-01-14 | — | — | CN | disclosed |
| WO-2014198241-A1 | THIO-1,2,4-TRIAZOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2014-12-18 | — | — | WO | disclosed |
| WO-2014198241-A1 | THIO-1,2,4-TRIAZOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2014-12-18 | — | — | WO | disclosed |
| US-8883824-B2 | 3-(4-aminophenyl)-2-furancarboxylic acid derivative and pharmaceutically acceptable salt thereof | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2014-11-11 | — | — | US | disclosed |
| US-8779163-B2 | Synthesis of UDP-Glucose: N-acylsphingosine glucosyl transferase inhibitors | GENZYME CORPORATION (US) | 2014-07-15 | — | — | US | disclosed |
| US-8779163-B2 | Synthesis of UDP-Glucose: N-acylsphingosine glucosyl transferase inhibitors | GENZYME CORPORATION (US) | 2014-07-15 | — | — | US | disclosed |
| US-8779163-B2 | Synthesis of UDP-Glucose: N-acylsphingosine glucosyl transferase inhibitors | GENZYME CORPORATION (US) | 2014-07-15 | — | — | US | disclosed |
| US-8716312-B2 | Inhibitors of diacylglycerol acyltransferase | MERCK SHARP & DOHME CORPORATION (US) | 2014-05-06 | — | — | US | disclosed |
| US-8696106-B1 | Thermally switchable transfix blanket made with grafted switchable polymer for indirect printing methods | XEROX CORPORATION (US) | 2014-04-15 | — | — | US | disclosed |
| US-20140086843-A1 | BIFUNCTIONAL HYDROXY-BISPHOSPHONIC ACID DERIVATIVES | ATLANTHERA (FR) | 2014-03-27 | — | — | US | disclosed |
| US-20140086843-A1 | BIFUNCTIONAL HYDROXY-BISPHOSPHONIC ACID DERIVATIVES | ATLANTHERA (FR) | 2014-03-27 | — | — | US | disclosed |
| US-20140031277-A1 | INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2014-01-30 | — | — | US | disclosed |
| US-20140010784-A1 | INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2014-01-09 | — | — | US | disclosed |
| CN-103408414-A | Preparation method of 2-hydroxyl-4-substituted arone compound | BEIJING GREENCHEM TECHNOLOGY CO LTD | 2013-11-27 | — | — | CN | disclosed |
| US-20130310383-A1 | 1-ARYL -1-HYDROXY -2,3-DIAMINO-PROPYL AMIN ES, 1-HETEROARYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES AND RELATED COMPOUNDS HAVING ANALGESIC AND/OR IMMUNO STIMULANT ACTIVITY | ALLERGAN, INC. (US) | 2013-11-21 | — | — | US | disclosed |
| EP-1841742-B1 | 3-HETEROARYL-3-HYDROXY-2-AMINO-PROPYL AMINES AND RELATED COMPOUNDS HAVING ANALGESIC AND/OR IMMUNO STIMULANT ACTIVITY | ALLERGAN INC (US) | 2013-10-30 | — | — | EP | disclosed |
| US-8569304-B2 | Active esters of N-substituted piperazine acetic acids, including isotopically enriched versions thereof | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2013-10-29 | — | — | US | disclosed |
| US-8536136-B2 | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2013-09-17 | — | — | US | disclosed |
| CN-103254203-A | Five-membered urea ring-coumarin derivative or pharmaceutical salt and application thereof | UNIV SICHUAN | 2013-08-21 | — | — | CN | disclosed |
| US-8513288-B2 | 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity | ALLERGAN, INC. (US) | 2013-08-20 | — | — | US | disclosed |
| EP-2251334-B1 | Labeling reagents and labeled analytes | DH TECHNOLOGIES DEV PTE LTD (SG) | 2013-08-14 | — | — | EP | disclosed |
| US-8486989-B2 | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2013-07-16 | — | — | US | disclosed |
| CN-101857518-B | Green synthesizing method of aryl bromide | UNIV ZHEJIANG TECHNOLOGY | 2013-04-24 | — | — | CN | disclosed |
| EP-2266968-B1 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors | GENZYME CORP (US) | 2013-01-09 | — | — | EP | disclosed |
| EP-2266968-B1 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors | GENZYME CORP (US) | 2013-01-09 | — | — | EP | disclosed |
| CN-102803249-A | Hepatitis c virus inhibitors | BRISTOL MYERS SQUIBB CO | 2012-11-28 | — | — | CN | disclosed |
| US-20120296088-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYL TRANSFERASE INHIBITORS | GENZYME CORPORATION | 2012-11-22 | — | — | US | disclosed |
| US-20120296088-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYL TRANSFERASE INHIBITORS | GENZYME CORPORATION | 2012-11-22 | — | — | US | disclosed |
| US-20120296088-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYL TRANSFERASE INHIBITORS | GENZYME CORPORATION | 2012-11-22 | — | — | US | disclosed |
| CN-102741242-A | Hepatitis c virus inhibitors | BRISTOL MYERS SQUIBB CO | 2012-10-17 | — | — | CN | disclosed |
| CN-102718748-A | Compounds having analgesic and/or immunostimulant activity | ALLERGAN INC | 2012-10-10 | — | — | CN | disclosed |
| WO-2012130911-A1 | BIFUNCTIONAL HYDROXY-BISPHOSPHONIC ACID DERIVATIVES | ATLANTHERA (FR) | 2012-10-04 | — | — | WO | disclosed |
| CN-102712628-A | Hepatitis c virus inhibitors | BRISTOL MYERS SQUIBB CO | 2012-10-03 | — | — | CN | disclosed |
| CN-102712623-A | Hepatitis c virus inhibitors | BRISTOL MYERS SQUIBB CO | 2012-10-03 | — | — | CN | disclosed |
| US-8273706-B2 | Isobarically labeled analytes and fragment ions derived therefrom | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2012-09-25 | — | — | US | disclosed |
| CN-102686565-A | Hepatitis c virus inhibitors | BRISTOL MYERS SQUIBB CO | 2012-09-19 | — | — | CN | disclosed |
| US-20120225881-A1 | METHODS OF USING AS ANALGESICS 1-BENZYL-1-HYDROXY-2, 3-DIAMINO-PROPYL AMINES, 3-BENZYL-3-HYRDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS | ALLERGAN, INC. | 2012-09-06 | — | — | US | disclosed |
| EP-2489658-A1 | 3-Heteroaryl-3-hydroxy-2-amino-propyl amines and related compounds having analgesic and/or immuno stimulant activity | Allergan, Inc. (US) | 2012-08-22 | — | — | EP | disclosed |
| CN-101151248-B | 3-Aryl-3-hydroxy-2-aminopropionic acid amides, 3-heteroaryl-3-hydroxy-2-aminopropionic acid amides and related compounds having analgesic and/or immunostimulant activity | ALLERGAN INC | 2012-06-20 | — | — | CN | disclosed |
| CN-102459281-A | Hepatitis c virus inhibitors | BRISTOL MYERS SQUIBB CO | 2012-05-16 | — | — | CN | disclosed |
| CN-102459239-A | Hepatitis c virus inhibitors | BRISTOL MYERS SQUIBB CO | 2012-05-16 | — | — | CN | disclosed |
| CN-102459250-A | Hepatitis c virus inhibitors | BRISTOL MYERS SQUIBB CO | 2012-05-16 | — | — | CN | disclosed |
| CN-102448956-A | Hepatitis c virus inhibitors | BRISTOL MYERS SQUIBB CO | 2012-05-09 | — | — | CN | disclosed |
| EP-2443482-A2 | BIOMEDICAL DEVICES | Bausch & Lomb Incorporated (US) | 2012-04-25 | — | — | EP | disclosed |
| EP-2443486-A2 | BIOMEDICAL DEVICES | Bausch & Lomb Incorporated (US) | 2012-04-25 | — | — | EP | disclosed |
| EP-2067775-B1 | A N-Acylsphingosine glucosyltransferase inhibitor | GENZYME CORP (US) | 2012-04-25 | — | — | EP | disclosed |
| EP-2067775-B1 | A N-Acylsphingosine glucosyltransferase inhibitor | GENZYME CORP (US) | 2012-04-25 | — | — | EP | disclosed |
| EP-2443485-A2 | BIOMEDICAL DEVICES | Bausch & Lomb Incorporated (US) | 2012-04-25 | — | — | EP | disclosed |
| EP-1937689-B1 | INTERMEDIATE AND PROCESS OF PREPARATION OF ECTEINASCIDINS SUCH AS ECTEINASCIDINS 583 AND 597 USING SUCH INTERMEDIATE | CENTRE NAT RECH SCIENT (FR) | 2012-04-18 | — | — | EP | disclosed |
| EP-1409467-B1 | A N-ACYLSPHINGOSINE GLUCOSYLTRANSFERASE INHIBITOR | GENZYME CORP (US) | 2012-04-18 | — | — | EP | disclosed |
| EP-1409467-B1 | A N-ACYLSPHINGOSINE GLUCOSYLTRANSFERASE INHIBITOR | GENZYME CORP (US) | 2012-04-18 | — | — | EP | disclosed |
| CN-102395579-A | Hepatitis c virus inhibitors | BRISTOL MYERS SQUIBB CO | 2012-03-28 | — | — | CN | disclosed |
| EP-2431362-A1 | 3-(4-AMINOPHENYL)-2-FURANCARBOXYLIC ACID DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | Dainippon Sumitomo Pharma Co., Ltd. (JP) | 2012-03-21 | — | — | EP | disclosed |
| US-8138353-B2 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors | GENZYME CORPORATION (US) | 2012-03-20 | — | — | US | disclosed |
| US-8138353-B2 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors | GENZYME CORPORATION (US) | 2012-03-20 | — | — | US | disclosed |
| US-8138353-B2 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors | GENZYME CORPORATION (US) | 2012-03-20 | — | — | US | disclosed |
| EP-2198864-B1 | Pharmaceutical compositions having an analgesic effect and containing 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino propionic acid amides or related compounds | ALLERGAN INC (US) | 2012-03-14 | — | — | EP | disclosed |
| CN-102378762-A | Hepatitis c virus inhibitors | BRISTOL MYERS SQUIBB CO | 2012-03-14 | — | — | CN | disclosed |
| US-20120059012-A1 | 3-(4-AMINOPHENYL)-2-FURANCARBOXYLIC ACID DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2012-03-08 | — | — | US | disclosed |
| CN-102304052-A | Method for preparing 5-bromo-2-hydroxy-3-nitroacetophenone | UNIV ZHEJIANG | 2012-01-04 | — | — | CN | disclosed |
| US-20110288094-A1 | 1-ARYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 1-HETEROARYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES AND RELATED COMPOUNDS HAVING ANALGESIC AND/OR IMMUNO STIMULANT ACTIVITY | ALLERGAN, INC. (US) | 2011-11-24 | — | — | US | disclosed |
| US-8058435-B2 | Intermediate and process of preparation of ecteinascidin such as ecteinascidines-583,597 using such intermediate | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2011-11-15 | — | — | US | disclosed |
| CN-102227407-A | Hepatitis c virus inhibitors | BRISTOL MYERS SQUIBB CO | 2011-10-26 | — | — | CN | disclosed |
| US-8039623-B2 | Peptidomimetics compound; viricides; interference in life cycle og hepatitis c virus | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2011-10-18 | — | — | US | disclosed |
| EP-2367598-A2 | INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE | Schering Corporation (US) | 2011-09-28 | — | — | EP | disclosed |
| US-20110224137-A1 | INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE | MERCK SHARP & DOHME CORP. | 2011-09-15 | — | — | US | disclosed |
| CN-102177141-A | bis-1H-benzimidazoles as hepatitis C virus inhibitors | BRISTOL MYERS SQUIBB CO | 2011-09-07 | — | — | CN | disclosed |
| US-8013000-B2 | 3-heteroaryl-3-hydroxy-2-amino-propyl amines and related compounds having analgesic and/or immuno stimlant activity | ALLERGAN, INC. (US) | 2011-09-06 | — | — | US | disclosed |
| EP-1829883-B1 | ORGANIC BISMUTH COMPOUND, METHOD FOR PRODUCING SAME, LIVING RADICAL POLYMERIZATION INITIATOR, METHOD FOR PRODUCING POLYMER USING SAME, AND POLYMER | OTSUKA CHEMICAL CO LTD (JP) | 2011-08-17 | — | — | EP | disclosed |
| CN-102143959-A | Hepatitis c virus inhibitors | BRISTOL MYERS SQUIBB CO | 2011-08-03 | — | — | CN | disclosed |
| US-7932388-B2 | Intermediates of active esters for peptide synthesis, labeling, analysis; purity | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2011-04-26 | — | — | US | disclosed |
| US-20110091957-A1 | PROTEIN-POLYMER CONJUGATES AND SYNTHESIS THEREOF | PITTSBURGH, UNIVERSITY OF - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2011-04-21 | — | — | US | disclosed |
| CN-102015692-A | Heterocyclic derivatives as hepatitis c virus inhibitors | BRISTOL MYERS SQUIBB CO | 2011-04-13 | — | — | CN | disclosed |
| CN-102007122-A | Imidazolyl biphenyl imidazoles as hepatitis c virus inhibitors | BRISTOL MYERS SQUIBB CO | 2011-04-06 | — | — | CN | disclosed |
| CN-101998954-A | Conformationally restricted biphenyl derivatives for use as hepatitis c virus inhibitors | BRISTOL MYERS SQUIBB CO | 2011-03-30 | — | — | CN | disclosed |
| CN-101998952-A | Hepatitis c virus inhibitors | BRISTOL MYERS SQUIBB CO | 2011-03-30 | — | — | CN | disclosed |
| US-20110003987-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYLTRANSFERASE INHIBITORS | GENZYME CORPORATION | 2011-01-06 | — | — | US | disclosed |
| US-20110003987-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYLTRANSFERASE INHIBITORS | GENZYME CORPORATION | 2011-01-06 | — | — | US | disclosed |
| US-20110003987-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYLTRANSFERASE INHIBITORS | GENZYME CORPORATION | 2011-01-06 | — | — | US | disclosed |
| US-20100330109-A1 | INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2010-12-30 | — | — | US | disclosed |
| EP-2266968-A2 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors | GENZYME CORPORATION (US) | 2010-12-29 | — | — | EP | disclosed |
| WO-2010147875-A2 | BIOMEDICAL DEVICES | BAUSCH & LOMB INCORPORATED (US) | 2010-12-23 | — | — | WO | disclosed |
| WO-2010147864-A2 | BIOMEDICAL DEVICES | BAUSCH & LOMB INCORPORATED (US) | 2010-12-23 | — | — | WO | disclosed |
| WO-2010147876-A2 | BIOMEDICAL DEVICES | BAUSCH & LOMB INCORPORATED (US) | 2010-12-23 | — | — | WO | disclosed |
| US-7847043-B2 | Organic bismuth compound, method for producing same, living radical polymerization initiator, method for producing polymer using same, and polymer | OTSUKA CHEMICAL CO., LTD. (JP) | 2010-12-07 | — | — | US | disclosed |
| EP-2251334-A1 | Labeling reagents and labeled analytes | Life Technologies Corporation (US) | 2010-11-17 | — | — | EP | disclosed |
| CN-101857518-A | Green synthesizing method of aryl bromide | UNIV ZHEJIANG TECHNOLOGY | 2010-10-13 | — | — | CN | disclosed |
| US-7795267-B2 | Bicyclic piperazine compound having TGR23 antagonistic activity | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-09-14 | — | — | US | disclosed |
| EP-1701945-B1 | LABELING REAGENTS, LABELED ANALYTES, INCLUDING MIXTURES THEREOF, AND FRAGMENT IONS DERIVED THEREFROM AND METHODS FOR THE ANALYSIS THEREOF | LIFE TECHNOLOGIES CORP (US) | 2010-09-01 | — | — | EP | disclosed |
| US-20100190792-A1 | METHODS FOR TREATING COGNITIVE DISORDERS USING 1-BENZYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 3-BENZYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS | ALLERGAN, INC | 2010-07-29 | — | — | US | disclosed |
| US-7763738-B2 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors | GENZYME CORPORATION (US) | 2010-07-27 | — | — | US | disclosed |
| US-7763738-B2 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors | GENZYME CORPORATION (US) | 2010-07-27 | — | — | US | disclosed |
| US-7763738-B2 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors | GENZYME CORPORATION (US) | 2010-07-27 | — | — | US | disclosed |
| US-20100173851-A1 | INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE | VERTEX PHARMACEUTICALS INCORPORATED | 2010-07-08 | — | — | US | disclosed |
| US-7745438-B2 | 3-(2-acylamino-1-hydroxyethyl)-morpholine derivatives and their use as bace inhibitors | ELI LILLY AND COMPANY (US) | 2010-06-29 | — | — | US | disclosed |
| EP-2198864-A1 | Pharmaceutical compositions having an analgesic effect and containing 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino propionic acid amides or related compounds | Allergan, Inc. (US) | 2010-06-23 | — | — | EP | disclosed |
| CN-101754966-A | Hepatitis c virus inhibitors | BRISTOL MYERS SQUIBB CO | 2010-06-23 | — | — | CN | disclosed |
| EP-1483228-B1 | NK1 ANTAGONISTS | SCHERING CORP (US) | 2010-06-02 | — | — | EP | disclosed |
| US-20100129842-A1 | ISOBARICALLY LABELED ANALYTES AND FRAGMENT IONS DERIVED THEREFROM | Life Technologies Corporation (US) | 2010-05-27 | — | — | US | disclosed |
| WO-2010059602-A2 | INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE | SCHERING CORPORATION (US) | 2010-05-27 | — | — | WO | disclosed |
| US-20100105687-A1 | METHODS FOR TREATING COGNITIVE DISORDERS USING 1-ARYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 1-HETEROARYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES AND RELATED COMPOUNDS | ALLERGAN, INC. (US) | 2010-04-29 | — | — | US | disclosed |
| US-7683033-B2 | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2010-03-23 | — | — | US | disclosed |
| EP-1841423-B1 | USE OF 1- BENZYL-1- HYDROXY-2, 3-DIAMINO-PROPYL AMINES, 3-BENZYL-3-HYDROXY-2-AMINO PROPIONIC ACID AMIDES AND RELATED COMPOUNDS AS ANALGESICS | ALLERGAN INC (US) | 2010-03-10 | — | — | EP | disclosed |
| US-20090312310-A1 | Imidazothiazole derivatives | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2009-12-17 | — | — | US | disclosed |
| CN-101605798-A | Imidazothiazole derivative | DAIICHI SANKYO CO LTD (JP) | 2009-12-16 | — | — | CN | disclosed |
| US-7615573-B2 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2009-11-10 | — | — | US | disclosed |
| US-7615573-B2 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2009-11-10 | — | — | US | disclosed |
| US-7615573-B2 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2009-11-10 | — | — | US | disclosed |
| WO-2009131805-A1 | NUCLEIC ACID TERMINATORS INCORPORATING A CATIONIC MOIETY AND METHODS FOR THEIR USE | Life Technologies Corporation (US) | 2009-10-29 | — | — | WO | disclosed |
| CN-101558059-A | Hepatitis C virus inhibitors | BRISTOL MYERS SQUIBB CO (US) | 2009-10-14 | — | — | CN | disclosed |
| EP-2103619-A1 | IMIDAZOTHIAZOLE DERIVATIVES | Daiichi Sankyo Company, Limited (JP) | 2009-09-23 | — | — | EP | disclosed |
| US-20090227791-A1 | Active Esters of N-Substituted Piperazine Acetic Acids, Including Isotopically Enriched Versions Thereof | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2009-09-10 | — | — | US | disclosed |
| EP-2091928-A2 | 3-(2-ACYLAMINO-1-HYDROXYETHYL)- MORPHOLINE DERIVATIVES AND THEIR USE AS BACE INHIBITORS | ELI LILLY AND COMPANY (US) | 2009-08-26 | — | — | EP | disclosed |
| US-20090176984-A1 | Isotopically Enriched N-Substituted Piperazine Acetic Acids And Methods For The Preparation Thereof | APPLIED BIOSYSTEMS, LLC | 2009-07-09 | — | — | US | disclosed |
| US-20090171080-A1 | Intermediate and Process of Preparation of Ecteinascidin Such as Ecteinascidines-583,597 Using Such Intermediate | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2009-07-02 | — | — | US | disclosed |
| CN-100506776-C | NK1 antagonists | SCHERING CORP (US) | 2009-07-01 | — | — | CN | disclosed |
| EP-2067775-A1 | Synthesis of UDP-glucose: N-Acylsphingosine glucosyltransferase inhibitors | GENZYME CORPORATION (US) | 2009-06-10 | — | — | EP | disclosed |
| EP-2067775-A1 | Synthesis of UDP-glucose: N-Acylsphingosine glucosyltransferase inhibitors | GENZYME CORPORATION (US) | 2009-06-10 | — | — | EP | disclosed |
| US-20090088433-A1 | METHODS OF USING AS ANALGESICS 1-BENZYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 3-BENZYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS | ALLERGAN, INC. | 2009-04-02 | — | — | US | disclosed |
| CN-100445281-C | Quinuclidine derivatives binding to muscarinic M3 receptor | NOVARTIS AG (CH) | 2008-12-24 | — | — | CN | disclosed |
| US-20080312236-A1 | 3-Heteroaryl-3-Hydroxy-2-Amino-Propyl Amines And Related Compounds Having Analgesic And/Or Immuno Stimlant Activity | EXONHIT THERAPEUTICS SA (FR) | 2008-12-18 | — | — | US | disclosed |
| US-7462676-B2 | Method for the controlled radical polymerisation of acrylic acid and the salts thereof, polymers thus obtained and applications thereof | COATEX S.A.S. (FR) | 2008-12-09 | — | — | US | disclosed |
| US-7452904-B2 | 1-alkyl-1-azoniabicyclo' 2.2.2 octane carbamate derivatives and their use as muscarinic receptor antagonists | CHIESI FARMACEUTICI S.P.A. (IT) | 2008-11-18 | — | — | US | disclosed |
| WO-2008109287-A1 | METHODS FOR TREATING COGNITIVE DISORDERS USING 1-BENZYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 3-BENZYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS | ALLERGAN, INC. (US) | 2008-09-12 | — | — | WO | disclosed |
| CN-100406439-C | Pyrrolidine derivatives as metalloprotease inhibitors | HOFFMANN LA ROCHE (CH) | 2008-07-30 | — | — | CN | disclosed |
| EP-1937689-A2 | INTERMEDIATE AND PROCESS OF PREPARATION OF ECTEINASCIDIN SUCH AS ECTEINASCIDINES-583, 597 USING SUCH INTERMEDIATE | Centre National de la Recherche Scientifique (FR) | 2008-07-02 | — | — | EP | disclosed |
| WO-2008069611-A1 | N-PHENYLAMIDE DERIVATIVE, PROCESS FOR THE PREPARATION THEREOF, AND COMPOSITION FOR PREVENTING OR TREATING ISCHEMIC DISEASES COMPRISING SAME | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2008-06-12 | — | — | WO | disclosed |
| US-20080114169-A1 | Isotopically enriched N-substituted piperazines and methods for the preparation thereof | APPLIED BIOSYSTEMS, LLC | 2008-05-15 | — | — | US | disclosed |
| US-7355045-B2 | Isotopically enriched N-substituted piperazine acetic acids and methods for the preparation thereof | APPLERA CORPORATION (US) | 2008-04-08 | — | — | US | disclosed |
| CN-101151248-A | 3-Aryl-3-hydroxy-2-aminopropionic acid amides, 3-heteroaryl-3-hydroxy-2-aminopropionic acid amides and related compounds having analgesic and/or immunostimulant activity | ALLERGAN INC (US) | 2008-03-26 | — | — | CN | disclosed |
| US-20080058514-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYLTRANSFERASE INHIBITORS | HIRTH BRADFORD H | 2008-03-06 | — | — | US | disclosed |
| US-20080058514-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYLTRANSFERASE INHIBITORS | HIRTH BRADFORD H | 2008-03-06 | — | — | US | disclosed |
| US-20080058514-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYLTRANSFERASE INHIBITORS | HIRTH BRADFORD H | 2008-03-06 | — | — | US | disclosed |
| US-20080045480-A1 | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | VERTEX PHARMACEUTICALS INCORPORATED | 2008-02-21 | — | — | US | disclosed |
| WO-2008011487-A2 | L-BENZYL-L-HYDR0XY-2, 3-DIAMIN0-PROPYL AMINES AND 3-BENZYL-3-HYDROXY-2-AMINO-PROPIONICACID AMIDES FOR CHRONIC PAIN | ALLERGAN, INC. (US) | 2008-01-24 | — | — | WO | disclosed |
| WO-2008011483-A2 | METHODS FOR TREATING CHRONIC PAIN USING 1- (HETERO) ARYL-1-HYDROXY 2,3-DIAMINO-PROPYL AMINES AND RELATED COMPOUNDS | ALLERGAN, INC. (US) | 2008-01-24 | — | — | WO | disclosed |
| US-20070292933-A1 | Inhibitors of serine proteases, particular HCV NS3-NS4A protease | PITLIK JANOS | 2007-12-20 | — | — | US | disclosed |
| US-7307169-B2 | Isotopically enriched N-substituted piperazines and methods for the preparation thereof | APPLERA CORPORATION (US) | 2007-12-11 | — | — | US | disclosed |
| US-20070265404-A1 | Organic Bismuth Compound, Method for Producing Same, Living Radical Polymerization Initiator, Method for Producing Polymer Using Same, and Polymer | OTSUKA CHEMICAL CO., LTD. (JP) | 2007-11-15 | — | — | US | disclosed |
| US-20070225267-A1 | 3-(2-Acylamino-1-Hydroxyethyl)-Morpholine Derivatives and Their Use as Bace Inhibitors | ELI LILLY AND COMPANY | 2007-09-27 | — | — | US | disclosed |
| US-7273885-B2 | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2007-09-25 | — | — | US | disclosed |
| EP-1829883-A1 | ORGANIC BISMUTH COMPOUND, METHOD FOR PRODUCING SAME, LIVING RADICAL POLYMERIZATION INITIATOR, METHOD FOR PRODUCING POLYMER USING SAME, AND POLYMER | Otsuka Chemical Co., Ltd. (JP) | 2007-09-05 | — | — | EP | disclosed |
| US-7265228-B2 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors | GENZYME CORPORATION (US) | 2007-09-04 | — | — | US | disclosed |
| US-7265228-B2 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors | GENZYME CORPORATION (US) | 2007-09-04 | — | — | US | disclosed |
| US-7265228-B2 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors | GENZYME CORPORATION (US) | 2007-09-04 | — | — | US | disclosed |
| US-20070203223-A1 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2007-08-30 | — | — | US | disclosed |
| US-20070203223-A1 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2007-08-30 | — | — | US | disclosed |
| US-20070203223-A1 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2007-08-30 | — | — | US | disclosed |
| US-20070161789-A1 | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | VERTEX PHARMACEUTICALS INCORPORATED | 2007-07-12 | — | — | US | disclosed |
| EP-1792904-A1 | Intermediate and process of preparation of ecteinascidin using such intermediate | Centre National de la Recherche Scientifique (CNRS) (FR) | 2007-06-06 | — | — | EP | disclosed |
| US-20070123646-A1 | Protein-polymer conjugates and synthesis thereof | PITTSBURGH, UNIVERSITY OF | 2007-05-31 | — | — | US | disclosed |
| US-20070106042-A1 | METHOD FOR THE CONTROLLED RADICAL POLYMERISATION OF ACRYLIC ACID AND THE SALTS THEREOF, POLYMERS THUS OBTAINED AND APPLICATIONS THEREOF | COATEX S.A.S. (FR) | 2007-05-10 | — | — | US | disclosed |
| WO-2007045686-A2 | INTERMEDIATE AND PROCESS OF PREPARATION OF ECTEINASCIDIN SUCH AS ECTEINASCIDINES-583, 597 USING SUCH INTERMEDIATE | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2007-04-26 | — | — | WO | disclosed |
| US-7208600-B2 | Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2007-04-24 | — | — | US | disclosed |
| US-20070072865-A1 | Bicyclic piperazine compound and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-03-29 | — | — | US | disclosed |
| US-7196205-B2 | Synthesis of amino ceramide-like compounds; for treating Tay-Sachs, Gaucher's or Fabry's disease; amenable to large scale preparations | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2007-03-27 | — | — | US | disclosed |
| US-7196205-B2 | Synthesis of amino ceramide-like compounds; for treating Tay-Sachs, Gaucher's or Fabry's disease; amenable to large scale preparations | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2007-03-27 | — | — | US | disclosed |
| US-7196205-B2 | Synthesis of amino ceramide-like compounds; for treating Tay-Sachs, Gaucher's or Fabry's disease; amenable to large scale preparations | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2007-03-27 | — | — | US | disclosed |
| US-7157537-B2 | α-Halogenated acid esters with polyvalent alcohols as atom transfer radical polymerization initiators | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-01-02 | — | — | US | disclosed |
| US-20060287298-A1 | Pharmaceutical for treatment of neurological and neuropsychiatric disorders | ALLELIX NEUROSCIENCE INC. | 2006-12-21 | — | — | US | disclosed |
| CN-1281588-C | Novel intermediate for prepn. of pyrazolopyrimidinones | PFIZER (US) | 2006-10-25 | — | — | CN | disclosed |
| EP-1701945-A1 | LABELING REAGENTS, LABELED ANALYTES, INCLUDING MIXTURES THEREOF, AND FRAGMENT IONS DERIVED THEREFROM AND METHODS FOR THE ANALYSIS THEREOF | Applera Corporation (US) | 2006-09-20 | — | — | EP | disclosed |
| US-7101912-B2 | Carbidopa prodrugs and derivatives, and compositions and uses thereof | XENOPORT, INC. (US) | 2006-09-05 | — | — | US | disclosed |
| EP-1014966-B1 | PHARMACEUTICAL FOR TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS | ALLELIX NEUROSCIENCE INC (US) | 2006-08-02 | — | — | EP | disclosed |
| CN-1807370-A | Method for preparing aromatic bromide by hydrobromic acid catalytic oxidation | DALIAN CHEMICAL PHYSICS INST (CN) | 2006-07-26 | — | — | CN | disclosed |
| CN-1784400-A | Quinuclidine derivatives binding to muscarinic M3 receptor | NOVARTIS AG (CH) | 2006-06-07 | — | — | CN | disclosed |
| EP-1661898-A1 | BICYCLIC PIPERAZINE COMPOUND AND USE THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2006-05-31 | — | — | EP | disclosed |
| US-20060111534-A1 | Method for the controlled radical polymerisation of acrylic acid and the salts thereof, polymers thus obtained and applications thereof | COATEX S.A.S. (FR) | 2006-05-25 | — | — | US | disclosed |
| WO-2006034093-A2 | 3- (2-ACYLAMINO-1-HYDROXYETHYL)- MORPHOLINE DERIVATIVES AND THEIR USE AS BACE INHIBITORS | ELLI LILLY AND COMPANY (US) | 2006-03-30 | — | — | WO | disclosed |
| US-7019024-B2 | Pharmaceutical for treatment of neurological and neuropsychiatric disorders | ALLELIX NEUROSCIENCE INC. (US) | 2006-03-28 | — | — | US | disclosed |
| CN-1724532-A | Colorant compound | XEROX CORP (US) | 2006-01-25 | — | — | CN | disclosed |
| CN-1714079-A | Mandelic acid derivatives | HOFFMANN LA ROCHE (CH) | 2005-12-28 | — | — | CN | disclosed |
| US-20050222244-A1 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors | GENZYME CORPORATION (US) | 2005-10-06 | — | — | US | disclosed |
| CN-1653025-A | NK1Antagonists | SCHERING CORP (US) | 2005-08-10 | — | — | CN | disclosed |
| WO-2005068446-A1 | LABELING REAGENTS, LABELED ANALYTES, INCLUDING MIXTURES THEREOF, AND FRAGMENT IONS DERIVED THEREFROM AND METHODS FOR THE ANALYSIS THEREOF | APPLERA CORPORATION (US) | 2005-07-28 | — | — | WO | disclosed |
| CN-1639112-A | Substituted amides having cannabinoid-1 receptor activity | MERCK & CO INC (US) | 2005-07-13 | — | — | CN | disclosed |
| US-20050148087-A1 | Isobarically labeled analytes and fragment ions derived therefrom | APPLERA CORPORATION | 2005-07-07 | — | — | US | disclosed |
| US-20050148771-A1 | Active esters of N-substituted piperazine acetic acids, including isotopically enriched versions thereof | APPLERA CORPORATION. | 2005-07-07 | — | — | US | disclosed |
| US-20050148773-A1 | Isotopically enriched N-substituted piperazines and methods for the preparation thereof | APPLERA CORPORATION. | 2005-07-07 | — | — | US | disclosed |
| US-20050147982-A1 | Mixtures of isobarically labeled analytes and fragments ions derived therefrom | APPLERA CORPORATION | 2005-07-07 | — | — | US | disclosed |
| US-20050147985-A1 | Mixtures of isobarically labeled analytes and fragments ions derived therefrom | APPLERA CORPORATION | 2005-07-07 | — | — | US | disclosed |
| US-20050148774-A1 | Isotopically enriched N-substituted piperazine acetic acids and methods for the preparation thereof | APPLERA CORPORATION. | 2005-07-07 | — | — | US | disclosed |
| CN-1626516-A | Novel intermediate for prepn. of pyrazolopyrimidinones | PFIZER (US) | 2005-06-15 | — | — | CN | disclosed |
| US-6878732-B2 | NK1 antagonists | SCHERING CORPORATION (US) | 2005-04-12 | — | — | US | disclosed |
| US-6855830-B2 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors | GENZYME CORPORATION (US) | 2005-02-15 | — | — | US | disclosed |
| CN-1188415-C | Pyrazolopyrimidinones inhibiting type 5 cyclic guanosine 3',5' -monophosphate phosphodiesterase (cG MP PDE5) for the treatment of sexual dysfunction | PFIZER LTD (US) | 2005-02-09 | — | — | CN | disclosed |
| US-20050009872-A1 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors | GENZYME CORPORATION (US) | 2005-01-13 | — | — | US | disclosed |
| US-20040260051-A1 | Alpha-halogenated acid esters with polyvalent alcohols as atom transfer radical polymerization initiators | CIBA SPECIALTY CHEMICALS CORP. | 2004-12-23 | — | — | US | disclosed |
| EP-1483228-A1 | NK1 ANTAGONISTS | SCHERING CORPORATION (US) | 2004-12-08 | — | — | EP | disclosed |
| EP-1458719-A1 | PYRIDOQUINOXALINE ANTIVIRALS | PHARMACIA & UPJOHN COMPANY (US) | 2004-09-22 | — | — | EP | disclosed |
| EP-1456208-A1 | PYRIDOQUINOXALINE ANTIVIRALS | PHARMACIA & UPJOHN COMPANY (US) | 2004-09-15 | — | — | EP | disclosed |
| EP-0950669-B1 | Method of catalytic crosslinking of polymers and two-pack composition used therein | ROHM & HAAS (US) | 2004-09-08 | — | — | EP | disclosed |
| US-20040167216-A1 | Carbidopa prodrugs and derivatives, and compositions and uses thereof | XIANG JIA-NING (US) | 2004-08-26 | — | — | US | disclosed |
| WO-2004052841-A1 | CARBIDOPA PRODRUGS AND USES THEREOF | XENOPORT, INC. (US) | 2004-06-24 | — | — | WO | disclosed |
| WO-2004048317-A1 | SUBSTITUTED AMIDES ACTIVE AT THE CANNABINOID-1 RECEPTOR | MERCK & CO., INC. (US) | 2004-06-10 | — | — | WO | disclosed |
| US-20040106596-A1 | Pyridoquinoxaline antivirals | PERRAULT WILLIAM R (US) | 2004-06-03 | — | — | US | disclosed |
| EP-1409467-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYLTRANSFERASE INHIBITORS | GENZYME CORPORATION (US) | 2004-04-21 | — | — | EP | disclosed |
| US-20040072854-A1 | NK1 antagonists | SCHERING CORPORATION | 2004-04-15 | — | — | US | disclosed |
| US-6686356-B2 | HERPES VIRUS | PHARMACIA & UPJOHN COMPANY | 2004-02-03 | — | — | US | disclosed |
| US-20030207877-A1 | Pyridoquinoxaline antivirals | PHARMACIA & UPJOHN COMPANY | 2003-11-06 | — | — | US | disclosed |
| WO-2003078376-A1 | NK1 ANTAGONISTS | SCHERING CORPORATION (US) | 2003-09-25 | — | — | WO | disclosed |
| CN-1443164-A | Pyrrolidine derivatives as metalloprotease inhibitors | HOFFMANN LA ROCHE (CH) | 2003-09-17 | — | — | CN | disclosed |
| US-20030130255-A1 | PYRIDOQUINOXALINE ANTIVIRALS | PHARMACIA & UPJOHN COMPANY | 2003-07-10 | — | — | US | disclosed |
| WO-2003053972-A1 | PYRIDOQUINOXALINE ANTIVIRALS | PHARMACIA & UPJOHN COMPANY (US) | 2003-07-03 | — | — | WO | disclosed |
| WO-2003053971-A1 | PYRIDOQUINOXALINE ANTIVIRALS | PHARMACIA & UPJOHN COMPANY (US) | 2003-07-03 | — | — | WO | disclosed |
| EP-1309609-A2 | LACTAM COMPOUNDS AND THEIR USE AS INHIBITORS OF SERINE PROTEASES AND METHOD | Bristol-Myers Squibb Company (US) | 2003-05-14 | — | — | EP | disclosed |
| US-20030050299-A1 | An intermediates for enantiomeric synthesis cermamide-like inhibitors; producing antilipemic agents | GENZYME CORPORATION | 2003-03-13 | — | — | US | disclosed |
| US-20030050299-A1 | An intermediates for enantiomeric synthesis cermamide-like inhibitors; producing antilipemic agents | GENZYME CORPORATION | 2003-03-13 | — | — | US | disclosed |
| US-20030050299-A1 | An intermediates for enantiomeric synthesis cermamide-like inhibitors; producing antilipemic agents | GENZYME CORPORATION | 2003-03-13 | — | — | US | disclosed |
| WO-2003008399-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYLTRANSFERASE INHIBITORS | GENZYME CORPORATION (US) | 2003-01-30 | — | — | WO | disclosed |
| WO-2002012196-A2 | LACTAM COMPOUNDS AND THEIR USE AS INHIBITORS OF SERINE PROTEASES AND METHOD | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-02-14 | — | — | WO | disclosed |
| US-6344450-B1 | LACTAM INHIBITORS OF SERINE PROTEASES SUCH AS FACTOR XA AND TRYPTASE, WHICH ARE USEFUL AS ANTICOAGULANTS IN THE TREATMENT OF CARDIOVASCULAR DISEASES ASSOCIATED WITH THROMBOSES, AND AS ANTI-INFLAMMATORY AGENTS PARTICULARLY IN THE TREATMENT OF | BRISTOL-MYERS SQUIBB COMPANY | 2002-02-05 | — | — | US | disclosed |
| EP-1163242-A2 | BICYCLIC HETEROCYCLES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESSES FOR PREPARING THEM | Boehringer Ingelheim Pharma KG (DE) | 2001-12-19 | — | — | EP | disclosed |
| CN-1327383-A | Pharmaceutical for treatment of neurological and neuropsychiatric disorders | ALERICS NEUROSCIENCE CO (US) | 2001-12-19 | — | — | CN | disclosed |
| US-6306991-B1 | TWO PART COATING COMPOSITION WITH TWO CONTAINERS, OXIDATIVE POLYMERS WITH CROSSLINKABLE FUNCTIONAL GROUPS | ROHM AND HAAS COMPANY | 2001-10-23 | — | — | US | disclosed |
| EP-1014966-A4 | PHARMACEUTICAL FOR TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS | ALLELIX NEUROSCIENCE INC (US) | 2001-10-04 | — | — | EP | disclosed |
| US-20010012857-A1 | Pharmaceutical for treatment of neurological and neuropsychiatric disorders | NPS PHARMACEUTICALS, INC. | 2001-08-09 | — | — | US | disclosed |
| CN-1288462-A | Oxazolidinone combinatorial libraries, compositions and method of prepn. | UPJOHN CO (US) | 2001-03-21 | — | — | CN | disclosed |
| US-6197791-B1 | ANTIARTHRITIC AGENTS; WOUND HEALING AGENTS; ANTITUMOR AGENTS | AMERICAN CYANAMID COMPANY | 2001-03-06 | — | — | US | disclosed |
| US-6191165-B1 | ANTIDEPRESSANTS; SCHIZOPHRENIA; ALZHEIMER'S DISEASE; ANTIEPILEPTIC AGENTS | ALLELIX NEUROSCIENCE INC. | 2001-02-20 | — | — | US | disclosed |
| US-6149977-A | CONTACTING THE OXIDATIVE POLYMER WITH A CATALYTIC AMOUNT OF AN OXIDIZING ENZYME, SUCH AS HORSERADISH PEROXIDASE. | ROHM AND HAAS COMPANY (US) | 2000-11-21 | — | — | US | disclosed |
| CN-1272114-A | Phenethylamine derivatives | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2000-11-01 | — | — | CN | disclosed |
| WO-2000055162-A2 | BICYCLIC HETEROCYCLES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESSES FOR PREPARING THEM | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2000-09-21 | — | — | WO | disclosed |
| EP-1014966-A1 | PHARMACEUTICAL FOR TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS | Allelix Neuroscience Inc. (US) | 2000-07-05 | — | — | EP | disclosed |
| CN-1253561-A | Pyrazolopyrimidinones inhibiting type 5 cyclic guanosine 3',5' -monophosphate phosphodiesterase (cGMP PDE5) for the treatment of sexual dysfunction | PFIZER LTD (US) | 2000-05-17 | — | — | CN | disclosed |
| EP-0970046-A1 | N-HYDROXY-2-(ALKYL, ARYL, OR HETEROARYL SULFANYL, SULFINYL OR SULFONYL)-3-SUBSTITUTED ALKYL, ARYL OR HETEROARYLAMIDES AS MATRIX METALLOPROTEINASE INHIBITORS | American Cyanamid Company (US) | 2000-01-12 | — | — | EP | disclosed |
| EP-0950669-A2 | Method of catalytic crosslinking of polymers and two-pack composition used therein | ROHM AND HAAS COMPANY (US) | 1999-10-20 | — | — | EP | disclosed |
| WO-1998038163-A1 | N-HYDROXY-2-(ALKYL, ARYL, OR HETEROARYL SULFANYL, SULFINYL OR SULFONYL)-3-SUBSTITUTED ALKYL, ARYL OR HETEROARYLAMIDES AS MATRIX METALLOPROTEINASE INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1998-09-03 | — | — | WO | disclosed |
| WO-1997045115-A1 | PHARMACEUTICAL FOR TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS | TROPHIX PHARMACEUTICALS, INC. (US) | 1997-12-04 | — | — | WO | disclosed |
| US-5623078-A | Process for producing an intermediate of a new quinolone compound | CHISSO CORPORATION (JP) | 1997-04-22 | — | — | US | disclosed |
| EP-0579738-B1 | IMPROVED PROCESS FOR PREPARING PHENYL ESTERS OF SUBSTITUTED ACIDS | DU PONT (US) | 1996-08-28 | — | — | EP | disclosed |
| EP-0537742-B1 | Styrene derivatives | MITSUBISHI CHEM CORP (JP) | 1996-08-21 | — | — | EP | disclosed |
| US-5514711-A | ANTICARCINOGENIC AGENTS; SIDE EFFECT REDUCTION | MITSUBISHI CHEMICAL CORPORATION (JP) | 1996-05-07 | — | — | US | disclosed |
| US-5371001-A | Transesterification in the presence of carboxy-esterases or carboxyamidases | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1994-12-06 | — | — | US | disclosed |
| CN-1089608-A | Imidazopyridine | MERCK PATENT GMBH (DE) | 1994-07-20 | — | — | CN | disclosed |
| US-5326887-A | Reacting ester of alpha hydroxy acid oligomer over fixed bed catalyst | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1994-07-05 | — | — | US | disclosed |
| EP-0579738-A1 | IMPROVED PROCESS FOR PREPARING PHENYL ESTERS OF SUBSTITUTED ACIDS. | DU PONT (US) | 1994-01-26 | — | — | EP | disclosed |
| US-5254718-A | Using enzyme catalyst; simplified separation, purification | E. I. DU PONT DE NEMOURS & COMPANY (US) | 1993-10-19 | — | — | US | disclosed |
| US-5235077-A | PROCESS FOR PREPARING PHENYL ESTERS OF SUBSTITUTED ACIDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-08-10 | — | — | US | disclosed |
| EP-0537742-A2 | Styrene derivatives | Mitsubishi Chemical Corporation (JP) | 1993-04-21 | — | — | EP | disclosed |
| WO-1992016492-A1 | IMPROVED PROCESS FOR PREPARING PHENYL ESTERS OF SUBSTITUTED ACIDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-10-01 | — | — | WO | disclosed |
| WO-1992015572-A1 | PROCESS FOR THE PREPARATION OF 1,4-DIOXANE-2,5-DIONES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-09-17 | — | — | WO | disclosed |
| EP-0417167-A1 | PROCESS FOR THE SYNTHESIS OF O-SUBSTITUTED OXIME COMPOUNDS | AlliedSignal Inc. (US) | 1991-03-20 | — | — | EP | disclosed |
| US-4973687-A | Synthesis of carbapenems using N-substituted azetidinones | BRISTOL-MYERS COMPANY (US) | 1990-11-27 | — | — | US | disclosed |
| US-4965397-A | Novel dibasic acid salts and their synthesis | ETHYL CORPORATION (US) | 1990-10-23 | — | — | US | disclosed |
| WO-1989011473-A1 | PROCESS FOR THE SYNTHESIS OF O-SUBSTITUTED OXIME COMPOUNDS | ALLIED-SIGNAL INC. (US) | 1989-11-30 | — | — | WO | disclosed |
| US-4769451-A | Synthesis of carbapenems using n-substituted azetidinones | BRISTOL-MYERS COMPANY (US) | 1988-09-06 | — | — | US | disclosed |
| US-4563310-A | HERBICIDES | ZOECON CORPORATION (US) | 1986-01-07 | — | — | US | disclosed |
| EP-0044119-B1 | PROCESS FOR THE PREPARATION OF COPOLYMERS OF ETHYLENE WITH AT LEAST ONE OTHER 1-ALKENE | STAMICARBON B.V. (NL) | 1985-05-29 | — | — | EP | disclosed |
| US-4487929-A | HYPOTENSIVE AGENTS | HOFFMANN-LA ROCHE, INC. (US) | 1984-12-11 | — | — | US | disclosed |
| US-4435552-A | COORDINATION CATALYST CONTAINING HALOACYL COMPOUND | STAMICARBON B.V. (NL) | 1984-03-06 | — | — | US | disclosed |
| US-4399136-A | Pyrazolopyridazine antihypertensives | HOFFMANN-LA ROCHE INC. (US) | 1983-08-16 | — | — | US | disclosed |
| EP-0065374-A1 | Substituted phosphinates and phosphinothioates and their use for the control of weeds | ZOECON CORPORATION (US) | 1982-11-24 | — | — | EP | disclosed |
| EP-0044119-A2 | Process for the preparation of copolymers of ethylene with at least one other 1-alkene | STAMICARBON B.V. (NL) | 1982-01-20 | — | — | EP | disclosed |
| US-4309428-A | Maytansinoids | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1982-01-05 | — | — | US | disclosed |
| EP-0025496-A1 | Maytansinoids, their production and therapeutic compositions containing them | Takeda Chemical Industries, Ltd. (JP) | 1981-03-25 | — | — | EP | disclosed |
| US-3953605-A | Antimicrobial quaternary ammonium compounds compositions | COLGATE-PALMOLIVE COMPANY (US) | 1976-04-27 | — | — | US | disclosed |
| US-3953605-A | Antimicrobial quaternary ammonium compounds compositions | COLGATE-PALMOLIVE COMPANY (US) | 1976-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (50 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080312236-A1 | 3-Heteroaryl-3-Hydroxy-2-Amino-Propyl Amines And Related Compounds Having Analgesic And/Or Immuno Stimlant Activity | OPRL1, OPRM1, MRGPRX2 | CYP19A1 1125/4885ELANE 1248/4885PTPN1 2158/4885 |
| US-20050147985-A1 | Mixtures of isobarically labeled analytes and fragments ions derived therefrom | NEFM, KLK3, SRMS | CYP19A1 646/4885ELANE 124/4885PTPN1 2719/4885 |
| US-20230039319-A1 | DEUTERIUM-ENRICHED SUBSTITUTED PHENOXYPHENYL ACETIC ACIDS AND ACYLSULFONAMIDES | AGTR2, AGTR1, EDNRA | CYP19A1 854/4885ELANE 622/4885PTPN1 2822/4885 |
| US-20090088433-A1 | METHODS OF USING AS ANALGESICS 1-BENZYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 3-BENZYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS | OPRL1, OPRK1, AADAT | CYP19A1 2049/4885ELANE 365/4885PTPN1 4652/4885 |
| US-20120296088-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYL TRANSFERASE INHIBITORS | UGCG, UGGT1, DPAGT1 | CYP19A1 3083/4885ELANE 3298/4885PTPN1 3198/4885 |
| US-20050222244-A1 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors | UGCG, UGGT1, DPAGT1 | CYP19A1 3114/4885ELANE 3651/4885PTPN1 3217/4885 |
| US-20140086843-A1 | BIFUNCTIONAL HYDROXY-BISPHOSPHONIC ACID DERIVATIVES | BPGM, PHPT1, PTH1R | CYP19A1 1586/4885ELANE 3145/4885PTPN1 821/4885 |
| US-20220081510-A1 | THERMOPLASTIC RESIN, OPTICAL FILM MADE THEREFROM, DIOL COMPOUND, DIESTER COMPOUND | RTF1, RNF10, RAD51 | CYP19A1 495/4885ELANE 2375/4885PTPN1 4604/4885 |
| US-10385042-B2 | Inhibitors of the enzyme UDP-glucose: N-acyl-sphingosine glucosyltransferase | UGCG, UGGT1, OGT | CYP19A1 2952/4885ELANE 1204/4885PTPN1 1351/4885 |
| US-20040167216-A1 | Carbidopa prodrugs and derivatives, and compositions and uses thereof | PDE3A, ADORA2A, CDA | CYP19A1 247/4885ELANE 1863/4885PTPN1 967/4885 |
| US-20070292933-A1 | Inhibitors of serine proteases, particular HCV NS3-NS4A protease | SERPINB1, PRSS1, SPINT2 | CYP19A1 2914/4885ELANE 56/4885PTPN1 1054/4885 |
| US-20210171507-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYLTRANSFERASE INHIBITORS | UGCG, UGGT1, DPAGT1 | CYP19A1 3114/4885ELANE 3651/4885PTPN1 3217/4885 |
| US-20100330109-A1 | INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE | PRSS1, SERPINB1, SPINT2 | CYP19A1 3102/4885ELANE 42/4885PTPN1 473/4885 |
| US-20050148774-A1 | Isotopically enriched N-substituted piperazine acetic acids and methods for the preparation thereof | NAA15, ALKBH5, GAP43 | CYP19A1 782/4885ELANE 681/4885PTPN1 4018/4885 |
| US-20130310383-A1 | 1-ARYL -1-HYDROXY -2,3-DIAMINO-PROPYL AMIN ES, 1-HETEROARYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES AND RELATED COMPOUNDS HAVING ANALGESIC AND/OR IMMUNO STIMULANT ACTIVITY | OPRL1, OPRM1, OPRK1 | CYP19A1 1585/4885ELANE 336/4885PTPN1 1153/4885 |
| US-20240409573-A1 | CALICHEAMICIN DERIVATIVES AND ANTIBODY DRUG CONJUGATES THEREOF | STT3A, CLSPN, STT3B | CYP19A1 3106/4885ELANE 3780/4885PTPN1 3712/4885 |
| US-20050148771-A1 | Active esters of N-substituted piperazine acetic acids, including isotopically enriched versions thereof | NAA15, EP300, ALKBH5 | CYP19A1 447/4885ELANE 321/4885PTPN1 3965/4885 |
| US-20040106596-A1 | Pyridoquinoxaline antivirals | IFNAR1, ZC3HAV1, SARS1 | CYP19A1 4448/4885ELANE 4528/4885PTPN1 145/4885 |
| US-20170334888-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYLTRANSFERASE INHIBITORS | UGCG, UGGT1, DPAGT1 | CYP19A1 3114/4885ELANE 3651/4885PTPN1 3217/4885 |
| US-20050148087-A1 | Isobarically labeled analytes and fragment ions derived therefrom | KLK3, SRMS, PTMS | CYP19A1 485/4885ELANE 333/4885PTPN1 3611/4885 |
| US-20030207877-A1 | Pyridoquinoxaline antivirals | IFNAR1, SARS1, ZC3HAV1 | CYP19A1 4599/4885ELANE 4532/4885PTPN1 241/4885 |
| US-20090312310-A1 | Imidazothiazole derivatives | TP53, MDM2, TP53BP1 | CYP19A1 2653/4885ELANE 4148/4885PTPN1 1765/4885 |
| US-20160083371-A1 | 1-ARYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 1-HETEROARYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES AND RELATED COMPOUNDS HAVING ANALGESIC AND/OR IMMUNO STIMULANT ACTIVITY | OPRM1, OPRL1, MYD88 | CYP19A1 1343/4885ELANE 955/4885PTPN1 902/4885 |
| US-20100105687-A1 | METHODS FOR TREATING COGNITIVE DISORDERS USING 1-ARYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 1-HETEROARYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES AND RELATED COMPOUNDS | SLC1A2, PNMT, HTR2C | CYP19A1 393/4885ELANE 3105/4885PTPN1 4595/4885 |
| US-20090227791-A1 | Active Esters of N-Substituted Piperazine Acetic Acids, Including Isotopically Enriched Versions Thereof | NAA15, EP300, ALKBH5 | CYP19A1 447/4885ELANE 321/4885PTPN1 3965/4885 |
| US-12037352-B2 | Perfluoropolyether compound containing carboxyl group | F12, AFF1, AFF4 | CYP19A1 146/4885ELANE 615/4885PTPN1 2237/4885 |
| US-20190345186-A1 | CALICHEAMICIN DERATIVES AND ANTIBODY DRUG CONJUGATES THEREOF | CALD1, CALU, STT3A | CYP19A1 2534/4885ELANE 3206/4885PTPN1 3214/4885 |
| US-11697644-B2 | Process for synthesis of eliglustat and intermediate compounds thereof | EPOR, FGFR1, ABL1 | CYP19A1 1003/4885ELANE 3910/4885PTPN1 3486/4885 |
| US-20070225267-A1 | 3-(2-Acylamino-1-Hydroxyethyl)-Morpholine Derivatives and Their Use as Bace Inhibitors | BACE1, BACE2, APP | CYP19A1 112/4885ELANE 3143/4885PTPN1 4822/4885 |
| US-20110003987-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYLTRANSFERASE INHIBITORS | UGCG, UGGT1, DPAGT1 | CYP19A1 3114/4885ELANE 3651/4885PTPN1 3217/4885 |
| US-20150148534-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYL TRANSFERASE INHIBITORS | UGCG, UGGT1, DPAGT1 | CYP19A1 3083/4885ELANE 3298/4885PTPN1 3198/4885 |
| US-20140031277-A1 | INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE | PRSS1, SERPINB1, SPINT2 | CYP19A1 3102/4885ELANE 42/4885PTPN1 473/4885 |
| US-20070265404-A1 | Organic Bismuth Compound, Method for Producing Same, Living Radical Polymerization Initiator, Method for Producing Polymer Using Same, and Polymer | DOHH, COASY, ODC1 | CYP19A1 497/4885ELANE 4349/4885PTPN1 4057/4885 |
| US-20100173851-A1 | INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE | SERPINB1, PRSS1, SPINT2 | CYP19A1 2863/4885ELANE 56/4885PTPN1 980/4885 |
| US-20060287298-A1 | Pharmaceutical for treatment of neurological and neuropsychiatric disorders | SLC18A2, SLC6A1, SLC6A11 | CYP19A1 2347/4885ELANE 2594/4885PTPN1 3858/4885 |
| US-20080058514-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYLTRANSFERASE INHIBITORS | UGCG, UGGT1, DPAGT1 | CYP19A1 3114/4885ELANE 3651/4885PTPN1 3217/4885 |
| US-20080114169-A1 | Isotopically enriched N-substituted piperazines and methods for the preparation thereof | ALKBH5, NPEPPS, PNMT | CYP19A1 827/4885ELANE 830/4885PTPN1 3715/4885 |
| US-11993625-B2 | Calicheamicin derivatives and antibody drug conjugates thereof | STT3A, CLSPN, STT3B | CYP19A1 3106/4885ELANE 3780/4885PTPN1 3712/4885 |
| US-20190322649-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYLTRANSFERASE INHIBITORS | UGCG, UGGT1, DPAGT1 | CYP19A1 3114/4885ELANE 3651/4885PTPN1 3217/4885 |
| US-20030130255-A1 | PYRIDOQUINOXALINE ANTIVIRALS | IFNAR1, ZC3HAV1, SARS1 | CYP19A1 4448/4885ELANE 4528/4885PTPN1 145/4885 |
| US-20100190792-A1 | METHODS FOR TREATING COGNITIVE DISORDERS USING 1-BENZYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 3-BENZYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS | SLC1A2, SLC1A1, GRIN2A | CYP19A1 2412/4885ELANE 2134/4885PTPN1 4722/4885 |
| US-20050148773-A1 | Isotopically enriched N-substituted piperazines and methods for the preparation thereof | ALKBH5, NPEPPS, PNMT | CYP19A1 827/4885ELANE 830/4885PTPN1 3715/4885 |
| US-20010012857-A1 | Pharmaceutical for treatment of neurological and neuropsychiatric disorders | SLC6A1, SLC18A2, SLC6A11 | CYP19A1 1631/4885ELANE 3003/4885PTPN1 2993/4885 |
| US-20070161789-A1 | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | PRSS1, SERPINB1, SPINT2 | CYP19A1 3102/4885ELANE 42/4885PTPN1 473/4885 |
| US-20040072854-A1 | NK1 antagonists | PROKR1, CRHR1, BDKRB2 | CYP19A1 2590/4885ELANE 765/4885PTPN1 3560/4885 |
| US-12065541-B2 | Thermoplastic resin, optical film made therefrom, diol compound, diester compound | RTF1, RNF31, RNF10 | CYP19A1 675/4885ELANE 2566/4885PTPN1 4319/4885 |
| US-11793881-B2 | Polyethylene glycol conjugate medicament, preparation method therefor and use thereof | SLC10A1, SLC10A2, NOTUM | CYP19A1 1536/4885ELANE 2714/4885PTPN1 595/4885 |
| US-20220185788-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF ELIGLUSTAT AND ITS INTERMEDIATE | OGFR, CYP3A4, HPD | CYP19A1 310/4885ELANE 3622/4885PTPN1 3253/4885 |
| US-20110224137-A1 | INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE | DGAT2, DGAT1, LCAT | CYP19A1 947/4885ELANE 3549/4885PTPN1 1660/4885 |
| US-20120059012-A1 | 3-(4-AMINOPHENYL)-2-FURANCARBOXYLIC ACID DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | ACSL3, SLCO4C1, SLC38A7 | CYP19A1 644/4885ELANE 2738/4885PTPN1 1684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.